3,4-dehydrocilostazol,
OPC-13015,
73963-62-9,
3,4-Dehydro Cilostazol,
3,4-Dehydrocilostazol,
opc-13015,
OPC 13015,
UNII-5M77W4SPE0,
5M77W4SPE0,
Cilostazol related compound B [USP],
QUI006,
SCHEMBL5811108,
CTK8F4797,
2(1H)-Quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-,
6-[4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL) BUTOXY]-2(1H)-QUINOLINONE,
ZINC22055506,
DB-049958,
FT-0665602,
Cilostazol related compound B,
2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-,
DTXSID60224705,
6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-1H-quinolin-2-one,
BCP16257,
AKOS027381697,
963D629,
6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)-butoxy]-2(1h)-quinolinone,
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-2(1H)-quinolinone,
3,4-Dehydrocilostazol (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one),
Cilostazol Related Compound B, United States Pharmacopeia (USP) Reference Standard,
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one (Cilostazol Related Compound B - USP), Pharmaceutical Secondary Standard; Certified Reference Material,
CS-T-14867,
CID10021885,
6-[4- BUTOXY]-2 -QUINOLINONE,
A13481,